This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 04/13/2021
Location: Virtual
Subject: 2021 FDA One Health Symposium: One Health Partnerships with FDA Centers and External Organizations
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Dennis Carroll (Global Virome Project); Jonna Mazet (University of California); Danielle Buttke (U.S. National Park Service); Casey Barton Behravesh (Centers for Disease Control and Prevention); Cyril Gay (U.S. Department of Agriculture); Helena Chapman, John Haynes (National Aeronautics and Space Administration)

Event Date: 04/13/2021
Location: Virtual
Subject: Patient-Centered Outcomes Research Institute (PCORI) Board of Governors Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of PCORI Board of Governors

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date :April 14, 2021
Location: Virtual
Subject: Drug Information Association (DIA)/FDA Biostatistics Industry and Regulator Virtual Forum; The Development and Deployment of COVID-19 Vaccines
FDA Participant/Group:
Non FDA Participant/Group: Industry

Event Date: April 15, 2021
Location: Virtual
Subject: Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC)
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group Industry; Public

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 04/14/2021
Location: Virtual
Subject: Consumer Technology Association (CTA) Tech Week; Speaker: Digital Health and Emerging Technologies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, and other stakeholders

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 4/19/2021
Location: Teams
Subject: CVM: Veterinary Issues of Mutual Interest
FDA Participant/Group: Timothy Schell, Tracey Forfa, Nadine Steinberg, Jeanette Murphy, Jennifer Erickson, Monique Sennett
Non FDA Participant/Group: Pet Food Industry (PFI)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event